R. Thomson et al., Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation, LANCET, 355(9208), 2000, pp. 956-962
Citations number
46
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Background Clinical guidelines are needed on whether or not to use anticoag
ulant therapy to prevent stroke in patients with non-valvular atrial fibril
lation. We did a Markov decision analysis to model decision-making with reg
ard to warfarin treatment in patients with atrial fibrillation, and used th
e model to develop evaluative guidelines.
Methods The decision analysis involved a systematic literature review suppl
emented by patients' estimates of the quality of life associated with diffe
rent states of health, secondary analysis of stroke-registry data, and esti
mation of service costs; it also incorporated a sensitivity analysis. The d
erived guidelines were subsequently applied to a cohort of patients with at
rial fibrillation,
Findings We constructed decision tables for 12 age and sex groups. For most
risk combinations, warfarin treatment would have decreased healthcare cost
s and increased quality-of-life years, although the clinical decision was s
ensitive to patients' preferences and to the estimate of warfarin's effecti
veness. 97% of women with atrial fibrillation older than 75 years, and 69%
aged 65-74 would have been recommended for treatment; for men, the correspo
nding figures would have been 75% and 53%, With the upper quartile for the
loss of quality of life associated with being on warfarin treatment (1.00),
all but two of the 116 patients without contraindications would have been
treated, whereas with the lower quartile (0.92), only 27 of 116 would have
been treated.
Interpretation Decision analysis is useful in the incorporation of complex
probabilistic data into informed decision-making, the identification of fac
tors influencing such decisions, and the subsequent development of evaluati
ve guidelines.